Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03641599
Other study ID # RV
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2017
Est. completion date July 1, 2018

Study information

Verified date August 2018
Source Benha University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Only a few studies evaluated the RV systolic function in the three categories of HF, regarding the importance of understanding changes in RV function on clinical presentation and outcome; it was essential to understand the prevalence and severity of RV dysfunction among the three groups and the degree of correlation between RV with LV systolic function.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date July 1, 2018
Est. primary completion date June 1, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

Adult patients of both gender who have the followiong criteria :

(i) symptoms with or without signs of HF (ii) elevated natriuretic peptides (BNP =35pg/ mL or NT-proBNP=125pg/mL) (iii) relevant structural heart disease: left ventricle hypertrophy (left ventricular mass index =115 g/m2 for males and =95 g/m2 for females) or left atrial enlargement (>34 mL/m2) or diastolic dysfunction (E/e'=13 and a mean e' septal and lateral wall <9 cm/s) were included.

Then patients were classified according to EF into HFpEF>50%, HFrEF<40% and HFmrEF >40% and <50%

Exclusion Criteria:

Patients with chronic obstructive pulmonary disease history of pulmonary embolism patients with respiratory failure

Study Design


Related Conditions & MeSH terms

  • Assessment of the RV Function in Patients With Heart Faliure
  • Heart Failure

Intervention

Diagnostic Test:
echocardiography
echocardiographic assessment of the RV and LV systolic function

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
shaimaa Mostafa

Outcome

Type Measure Description Time frame Safety issue
Primary assessment of the RV systolic dysfunction in patients with heart failure degree and prevalence of the RV systolic dysfunction in patients with heart failure with preserved, mid-range and decreased ejection fraction 1.5 year